Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04900337 |
|---|---|
| Brief Title: | Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) Compared to Placebo and Best Available Care (BAT), for the Treatment of Moderate to Severe COVID-19 Patients. |
| First Submitted : | May 19, 2021 |
| First Submitted that Met QC Criteria : | May 23, 2021 |
| First Posted : | May 25, 2021 |
| Last Update Submitted that Met QC Criteria : | May 23, 2021 |
| Last Update Posted : | May 25, 2021 |